Abstract: FR-PO1096
Natural Language Processing Artificial Intelligence (AI) Predicts CKD Progression in Medical-Word Virtual Space
Session Information
- CKD: Epidemiology, Risk Factors, and Prevention - 2
October 25, 2024 | Location: Exhibit Hall, Convention Center
Abstract Time: 10:00 AM - 12:00 PM
Category: CKD (Non-Dialysis)
- 2301 CKD (Non-Dialysis): Epidemiology, Risk Factors, and Prevention
Authors
- Kanda, Eiichiro, Kawasaki Ika Daigaku, Kurashiki, Okayama, Japan
- Epureanu, Bogdan I., University of Michigan, Ann Arbor, Michigan, United States
- Adachi, Taiji, Kyoto Daigaku, Kyoto, Japan
- Sasaki, Tamaki, Kawasaki Ika Daigaku, Kurashiki, Okayama, Japan
- Kashihara, Naoki, Kawasaki Ika Daigaku, Kurashiki, Okayama, Japan
Background
Chronic kidney disease (CKD) leads to end-stage renal disease (ESRD) or death. A new surrogate marker reflecting its pathophysiology has been needed for CKD therapy.
Methods
In this study, we developed a virtual space where data in medical words and those of actual CKD patients were unified by natural language processing and category theory.
Results
A virtual space of medical words was constructed from the CKD-related literature (n=165,271) using Word2Vec, in which 106,612 words composed a network. The network satisfied the definition of vector calculations, and retained the meanings of medical words. The data of CKD patients of a cohort study for 3 years (n=26,433) were transformed into the network as medical-word vectors. We let the relationship between vectors of patient data and the outcome (dialysis or death) be a marker (inner product). Then, the inner product accurately predicted the outcomes: C-statistics of 0.911 (95% CI 0.897, 0.924). Cox proportional hazards models showed that the risk of the outcomes in the high-inner-product group was 21.92 (95% CI 14.77, 32.51) times higher than that in the low-inner-product group.
Conclusion
This study showed that CKD patients can be treated as a network of medical words that reflect the pathophysiological condition of CKD and the risks of CKD progression and mortality.